» Articles » PMID: 19013326

Acute Kidney Injury in HIV-infected Patients

Overview
Journal Semin Nephrol
Specialty Nephrology
Date 2008 Nov 18
PMID 19013326
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury is common in human immunodeficiency virus (HIV)-infected patients, and has been associated with increased morbidity and mortality. Before the introduction of effective antiretroviral therapy, acute kidney injury in HIV-positive patients was most commonly the result of volume depletion, septicemia, or nephrotoxic medications. Acute kidney injury remains a significant problem in the antiretroviral era, and still commonly is attributed to infection or nephrotoxic medications. Less common causes such as direct infectious insults, immune restoration inflammatory syndrome, rhabdomyolysis, and obstruction should be considered when the underlying process is not obvious. In addition to advanced HIV disease, several other patient characteristics have emerged as potential risk factors for acute kidney injury in the antiretroviral era, including older age, diabetes, pre-existing chronic kidney disease, and hepatitis co-infection or liver disease.

Citing Articles

Urogenital Manifestations in Mpox (Monkeypox) Infection: A Comprehensive Review of Epidemiology, Pathogenesis, and Therapeutic Approaches.

He S, Zhao J, Chen J, Liang J, Hu X, Zhang X Infect Drug Resist. 2025; 18():209-226.

PMID: 39816240 PMC: 11733167. DOI: 10.2147/IDR.S504280.


Incidence of Acute Kidney Injury and Associated Mortality among Individuals with Drug-Susceptible Tuberculosis in Uganda.

Kansiime G, Aklilu A, Baluku J, Yasmin F, Kanyesigye M, Muzoora C Kidney360. 2024; 5(10):1446-1454.

PMID: 39141693 PMC: 11556924. DOI: 10.34067/KID.0000000000000551.


A systematic review assessing the potential use of cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy.

Hanser S, Choshi J, Mokoena H, Mabhida S, Mchiza Z, Moetlediwa M Front Med (Lausanne). 2024; 11:1295217.

PMID: 38566923 PMC: 10985183. DOI: 10.3389/fmed.2024.1295217.


Acute kidney injury and its predictors among HIV-positive patients in Africa: Systematic review and meta-analysis.

Azagew A, Abate H, Ferede Y, Mekonnen C PLoS One. 2024; 19(2):e0298302.

PMID: 38335171 PMC: 10857608. DOI: 10.1371/journal.pone.0298302.


Drug-drug interactions between COVID-19 therapeutics and antiretroviral treatment: the evidence to date.

Ellis C, Inaba K, Van de Vuurst C, Ghrayeb A, Cory T Expert Opin Drug Metab Toxicol. 2023; 19(11):795-806.

PMID: 37800561 PMC: 10841549. DOI: 10.1080/17425255.2023.2267970.


References
1.
Gupta S, Eustace J, Winston J, Boydstun I, Ahuja T, Rodriguez R . Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005; 40(11):1559-85. DOI: 10.1086/430257. View

2.
Sutor G, Schmidt R, Albrecht H . Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP, and review of the literature. Infection. 1999; 27(1):12-5. DOI: 10.1007/BF02565164. View

3.
Becker S, Fusco G, Fusco J, Balu R, Gangjee S, Brennan C . HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study. Clin Infect Dis. 2004; 39 Suppl 5:S267-75. DOI: 10.1086/422363. View

4.
Sherman K, Rouster S, Chung R, Rajicic N . Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002; 34(6):831-7. DOI: 10.1086/339042. View

5.
Valeri A, Neusy A . Acute and chronic renal disease in hospitalized AIDS patients. Clin Nephrol. 1991; 35(3):110-8. View